Specifically, in breast cancer, it was shown that loss of wild-type p53 in tumor cells can lead to the compromised ability of preadipocytes to undergo terminal differentiation, and instead they were reprogrammed toward an inflammatory cell state autonomously [15]. This evidence concerns the gene TP53 and breast cancer.